(Total Views: 653)
Posted On: 01/23/2021 9:25:06 AM
Post# of 145249
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Recent article for leronlimab as therapy for TNBC.
Research article
Open Access
Published: 23 January 2021
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
https://breast-cancer-research.biomedcentral....21-01391-1
Research article
Open Access
Published: 23 January 2021
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
https://breast-cancer-research.biomedcentral....21-01391-1
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)